Products & ReviewLife Sciences

GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG Antibody to Spike RBD protein Quantitative TITRATION ELISA

ELISA for the quantitative determination of IgG Antibodies to SARS-CoV-2 Spike Protein in mouse serum and plasma. Accurate, specific detection with reproducible results.

KRISHGEN BioSystems

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Average Rating 3.0

|1Scientists have reviewed this product

Ease of Use
After Sales Service
Value for Money
Write your own review

Wonderful results with high quality

 

Average Rating 3.0

Application Area:

Covid-19 vaccination

Wonderful results with high quality

Review Date: 14 Mar 2023 | KRISHGEN BioSystems

This range of mouse ELISA is currently being used for pre-clinical assessment and validation of vaccines against SARS-CoV-2 including:

  • Selection of a novel candidate
  • Immunization studies
  • Titration of antibodies – toxicology
  • Other in-vitro studies

These specifically designed ELISA can be used for different kinds of vaccines being developed in the industry - specific for S1, S2 or RBD; both mRNA based, and DNA based.

About the SARS-CoV-2 Mouse IgG to Spike RBD Assay:

  • Based on monoclonal antibody detection for better sensitivity. A sandwich ELISA design and highly specific antibodies (rated highly specific in a study done by PATH) allow for a robust ELISA with low cross reactivity.
  • Standard, ready-to-use protocol
  • The option to run serum or plasma samples
  • Ships in 2 days at ambient temperature
  • Developed against seven-step validation process, as per ICH and FDA guidelines for biological assays
  • Calibrator Range: 0 ng/ml - 720 ng/ml
  • Sensitivity: 12 ng/ml
  • Sample Type: Serum, Plasma
  • Reactivity: Mouse
  • Shipping Condition: 2 - 8 Deg C
  • Detection Method: Colorimetric
  • Usage: For Research Use Only
  • Research Area: COVID-19

Product Overview

Links